Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$18.6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 50 most recent Form 4 transactions.
| Jun 5 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 8,437 | $67.88 | $572.7K | -0.2% | Open the original filing on SEC.gov |
| Jun 5 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 7,148 | $67.20 | $480.3K | -0.2% | Open the original filing on SEC.gov |
| Jun 5 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 4,416 | $68.96 | $304.5K | -0.9% | Open the original filing on SEC.gov |
| Jun 5 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 8,437 | $67.88 | $572.7K | -1.6% | Open the original filing on SEC.gov |
| Jun 5 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 7,147 | $67.20 | $480.3K | -1.3% | Open the original filing on SEC.gov |
| Jun 4 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 450 | $68.27 | $30.7K | <0.1% | Open the original filing on SEC.gov |
| Jun 4 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 15,921 | $67.74 | $1.1M | -0.4% | Open the original filing on SEC.gov |
| Jun 4 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 1,429 | $66.72 | $95.3K | <0.1% | Open the original filing on SEC.gov |
| Jun 4 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 2,200 | $65.72 | $144.6K | <0.1% | Open the original filing on SEC.gov |
| Jun 4 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 450 | $68.27 | $30.7K | <0.1% | Open the original filing on SEC.gov |
| Jun 4 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 15,921 | $67.74 | $1.1M | -2.9% | Open the original filing on SEC.gov |
| Jun 4 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 1,429 | $66.72 | $95.3K | -0.3% | Open the original filing on SEC.gov |
| Jun 4 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 2,200 | $65.72 | $144.6K | -0.4% | Open the original filing on SEC.gov |
| May 21 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 800 | $70.92 | $56.7K | -0.3% | Open the original filing on SEC.gov |
| May 21 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 11,250 | $70.48 | $792.9K | -4.4% | Open the original filing on SEC.gov |
| May 21 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 5,072 | $69.22 | $351.1K | -1.9% | Open the original filing on SEC.gov |
| May 21 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 6,725 | $68.30 | $459.3K | -2.5% | Open the original filing on SEC.gov |
| May 21 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 2,256 | $67.57 | $152.4K | -0.8% | Open the original filing on SEC.gov |
| May 16 | BBIO | BridgeBio Pharma, Inc. | MEXER◆ | 6,519 | — | — | — | Open the original filing on SEC.gov |
| May 16 | BBIO | BridgeBio Pharma, Inc. | MEXER◆ | 11,553 | — | — | — | Open the original filing on SEC.gov |
| May 16 | BBIO | BridgeBio Pharma, Inc. | MEXER◆ | 19,599 | — | — | — | Open the original filing on SEC.gov |
| May 16 | BBIO | BridgeBio Pharma, Inc. | MEXER◆ | 33,544 | — | — | — | Open the original filing on SEC.gov |
| May 16 | BBIO | BridgeBio Pharma, Inc. | FTAX | 36,236 | $66.13 | $2.4M | -11.8% | Open the original filing on SEC.gov |
| May 16 | BBIO | BridgeBio Pharma, Inc. | MEXER | 6,519 | — | — | +2.2% | Open the original filing on SEC.gov |
| May 16 | BBIO | BridgeBio Pharma, Inc. | MEXER | 11,553 | — | — | +4.0% | Open the original filing on SEC.gov |
| May 16 | BBIO | BridgeBio Pharma, Inc. | MEXER | 19,599 | — | — | +7.3% | Open the original filing on SEC.gov |
| May 16 | BBIO | BridgeBio Pharma, Inc. | MEXER | 33,544 | — | — | +14.3% | Open the original filing on SEC.gov |
| May 8 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 950 | $68.35 | $64.9K | <0.1% | Open the original filing on SEC.gov |
| May 8 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 5,076 | $67.35 | $341.8K | -0.1% | Open the original filing on SEC.gov |
| May 8 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 13,974 | $66.65 | $931.4K | -0.3% | Open the original filing on SEC.gov |
| May 8 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 950 | $68.35 | $64.9K | -0.2% | Open the original filing on SEC.gov |
| May 8 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 5,077 | $67.35 | $341.9K | -0.9% | Open the original filing on SEC.gov |
| May 8 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 13,973 | $66.65 | $931.3K | -2.4% | Open the original filing on SEC.gov |
| May 7 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 449 | $69.09 | $31K | <0.1% | Open the original filing on SEC.gov |
| May 7 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 8,334 | $68.38 | $569.9K | -0.2% | Open the original filing on SEC.gov |
| May 7 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 11,217 | $67.49 | $757.1K | -0.3% | Open the original filing on SEC.gov |
| May 7 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 450 | $69.09 | $31.1K | <0.1% | Open the original filing on SEC.gov |
| May 7 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 8,333 | $68.38 | $569.8K | -1.4% | Open the original filing on SEC.gov |
| May 7 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 11,217 | $67.50 | $757.1K | -1.9% | Open the original filing on SEC.gov |
| Apr 10 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 20,000 | $74.60 | $1.5M | -0.4% | Open the original filing on SEC.gov |
| Apr 10 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 20,000 | $74.60 | $1.5M | -3.3% | Open the original filing on SEC.gov |
| Apr 9 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 7,800 | $75.53 | $589.1K | -0.2% | Open the original filing on SEC.gov |
| Apr 9 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 5,128 | $74.57 | $382.4K | -0.1% | Open the original filing on SEC.gov |
| Apr 9 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 7,072 | $73.64 | $520.8K | -0.2% | Open the original filing on SEC.gov |
| Apr 9 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 7,500 | $75.55 | $566.7K | -1.2% | Open the original filing on SEC.gov |
| Apr 9 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 5,300 | $74.60 | $395.4K | -0.8% | Open the original filing on SEC.gov |
| Apr 9 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 7,200 | $73.64 | $530.2K | -1.1% | Open the original filing on SEC.gov |
| Mar 27 | MAZE | Maze Therapeutics, Inc. | AGRANT◆ | 33,417 | — | — | — | Open the original filing on SEC.gov |